Status:
UNKNOWN
Prognosis of Extremely Premature Birth
Lead Sponsor:
University of Bergen
Collaborating Sponsors:
Haukeland University Hospital
Helse Stavanger HF
Conditions:
Infant, Premature, Diseases
Perinatal Morbidity
Eligibility:
All Genders
22-27 years
Brief Summary
Pregnant women at risk of giving birth before 28 weeks' gestational age will be enrolled. Fetal circulation will be studied and blood for inflammatory parameters will be collected. If birth occurs bef...
Detailed Description
The study includes a regional cohort (Western Norway) of approximately 50 extremely preterm infants born per year over a three year period. Detailed information on fetal condition (growth, circulation...
Eligibility Criteria
Inclusion
- Born with gestational age less than 28 weeks
Exclusion
- None
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01150396
Start Date
July 1 2010
End Date
December 1 2018
Last Update
June 2 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, N-5021
2
Stavanger University Hospital
Stavanger, Norway, N-4011